Understanding of latent tuberculosis, its treatment and treatment side effects in immigrant and refugee patients

BMC Research Notes

Caroline Marshall²  Daniel O’Brien¹  Chris Lemoh²  Karin Leder⁴  Beverley-Ann Biggs²  Katie Butcher³ 

[1] Department of Infectious Diseases, Geelong Hospital, Bellerine Street, Geelong, Victoria 3220, Australia;Victorian Infectious Diseases Service, Royal Melbourne Hospital, Grattan St Parkville, Victoria 3050, Australia;Department of Medicine, University of Melbourne, Grattan St Parkville, Victoria 3050, Australia;Department of Epidemiology and Preventive Medicine, Monash University, 99 Commercial Road, Melbourne, Victoria 3000, Australia

关键词: Refugee;    Immigrant;    Health literacy;    Latent tuberculosis infection;   

Others  :  1141798
DOI  :  10.1186/1756-0500-6-342

 received in 2013-05-21, accepted in 2013-08-26,  发布年份 2013

【 摘 要 】

Background

Isoniazid treatment of latent tuberculosis infection (LTBI) is commonly prescribed in refugees and immigrants. We aimed to assess understanding of information provided about LTBI, its treatment and potential side effects.

Methods

A questionnaire was administered in clinics at a tertiary hospital. Total Knowledge (TKS) and Total Side Effect Scores (TSES) were derived. Logistic regression analyses were employed to correlate socio-demographic factors with knowledge.

Results

Fifty-two participants were recruited, 20 at isoniazid commencement and 32 already on isoniazid. The average TKS were 5.04/9 and 6.23/9 respectively and were significantly associated with interpreter use. Approximately half did not know how tuberculosis was transmitted. The average TSES were 5.0/7 and 3.5/7 respectively, but were not influenced by socio-demographic factors.

Conclusions

There was suboptimal knowledge about LTBI. Improvements in health messages delivered via interpreters and additional methods of distributing information need to be developed for this patient population.

【 授权许可】

   
2013 Butcher et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Walls T, Shingadia D: The epidemiology of tuberculosis in Europe. Arch Dis Child 2007, 92:726-729.
• [2]Levesque JF, Dongier PBP: Acceptance of screening and completion of treatment for latent tuberculosis infection among refugee claimants in Canada. Int J Tuberc Lung Dis 2004, 8:711-717.
• [3]Cain KP, Haley CA, Armstrong LR: Tuberculosis among foreign-born persons in the United States. Am J Resp Crit Care Med 2007, 175:75-79.
• [4]Gibney KB, Leder K, Torresi J, Marshall C, Matchett E, Ebeling PR, Biggs BA: Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from Sub-Saharan Africa. Clin Infect Dis 2008, 46:443-446.
• [5]Matteelli A, Casalini C, Raviglione MC, Scolari C, Bombana E: Supervised preventive therapy for latent tuberculosis infection in illegal immigrants in Italy. Am J Resp Crit Care Med 2000, 162:1653-1655.
• [6]Centers for Disease Control and Prevention: Trends in tuberculosis- United States, 2008. Morb Mortal Weekly Report 2009, 58:249-253.
• [7]Lopez-Velez R, Huerga H, Turrientes MC: Infectious diseases in immigrants from the perspective of a tropical medicine referral unit. Am J Trop Med Hyg 2003, 69:115-121.
• [8]World Health Organisation: Australia tuberculosis profile 2009. World Health Organisation; 2011. http://www.who.int/tb/country/data/profiles/en/index.html webcite
• [9]Marks GB, Bai J, Simpson SE: Incidence of tuberculosis among a cohort of tuberculin-positive refugees in Australia: Am J Resp Crit Care Med. 2000, 162:1851-1854.
• [10]Gibney KB, Mihrshahi S, Torresi J, Marshall C, Leder K, Biggs BA: The profile of health problems in African immigrants attending an infectious disease unit in Melbourne, Australia. Am J Trop Med Hyg 2009, 80:805-811.
• [11]Maartens G, Wilkinson R: J: Tuberculosis. Lancet. 2007, 370:2030-2043.
• [12]Centers for Disease Control and Prevention: Core curriculum on tuberculosis. 4th edition. Atlanta, GA: National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention; 2008.
• [13]Hirsch-Moverman Y, Daftary A, Franks J, Colson PW: Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada. Int J Tuberc Lung Dis 2008, 12:1235-1254.
• [14]Ailinger RL, Armstrong R, Nguyen N, Lasus H: Latino immigrants’ knowledge of tuberculosis. Pub Health Nursing 2004, 21:519-923.
• [15]American Thoracic Society and Centers for Disease Control and Prevention: Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Resp Crit Care Med 2000, 161:S221-S247.
• [16]Menzies D, Long R, Trajman A: Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis infection. Ann Int Med 2008, 149:689-697.
• [17]Page KR, Sifakis F, Montes De Oca R, Cronin WA, Doherty MC, Federline L, Bur S, Walsh T, Karney W, Milman J, Baruch N, Adelakun A, Dorman SE: Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study. Arch Intern Med 2006, 166:1863-1870.
• [18]Alilinger RL, Moore JB, Nguyen N, Lasus H: Adherence to latent tuberculosis infection therapy among Latino immigrants. Public Health Nurs 2006, 23:307-313.
• [19]Ito KL: Health culture and the clinical encounter: Vietnamese refugees’ responses to preventive drug treatment of inactive tuberculosis. Med Anthropol Q 1999, 13:338-364.
• [20]Hess K, Goad J, Wu J, Johnson K: Isoniazid completion rates of latent tuberculosis infection among college students managed by a community pharmacist. J Am Coll Health 2009, 57:553-555.
• [21]Wyss LL, Alderman MK: Using theory to interpret beliefs in migrants diagnosed with latent TB. Online J Iss Nurs 2006, 12:7.
• [22]Hovell M, Blumberg E, Gil-Trejo L: Predictors of adherence to treatment for latent tuberculosis infection in high-risk Latino adolescents: a behavioral epidemiological analysis. Soc Sci Med 2003, 56:1789-1796.
• [23]Shieh FK, Snyder G, Horsburgh CR, Bernardo J: Predicting non-completion of treatment for latent tuberculosis infection. Am J Resp Crit Care Med 2006, 174:717-721.
• [24]Coreil J, Lauzardo M, Heurtelou M: Cultural feasibility assessment of tuberculosis prevention among persons of Haitian origin in South Florida. J Imm Health 2004, 6:63-69.
• [25]Kamo K, Yanagihara H, Satoh K: Bias-corrected AIC for selecting variables in Poisson regression models. Commun Stat Theory Methods 2013, 42:1911-1921.
• [26]Houston HR, Harada N, Makinodan T: Development of a culturally sensitive educational intervention program to reduce the high incidence of tuberculosis among foreign-born Vietnamese. Ethn Health 2002, 7:255-257.
• [27]Centers for Disease Control and Prevention: Recommendations for Use of an isoniazid-rifapentine regimen with direct observation to treat latent mycobacterium tuberculosis infection. MMWR 2011, 60:1650-1653.